Edgewise Therapeutics jumps 12% on reports of takeover interest
Edgewise Therapeutics shares rose 12% after a report of possible buyer interest. Seeking Alpha says the company may have hired advisers to run a sale.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Edgewise Therapeutics shares climbed 12%, and according to Seeking Alpha, the gain was at least partly driven by a report that the biopharmaceutical firm has drawn takeover interest. Traders citing a Betaville alert marked "uncooked", which circulated on Friday, said Edgewise may have hired advisers to run a sales process.
The same report says two European pharmaceutical companies and one US-listed company may be involved in the process over the past two months. The stock had already risen 3.6% on Thursday.
why it matters
Takeover rumours usually support the share price of a target while the market waits for confirmation or denial. If talks do not lead to a deal, part of the premium can fade quickly.
market impact
Edgewise shares: takeover rumours support the stock price
- Edgewise Therapeutics shares pressure up — takeover speculation adds a premium to the share price
tags
instruments
sources
- Edgewise Therapeutics gains amid report of takeover interest — Seeking Alpha, 6 November 2026 at 16:47 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗